Project: The development of an easy-to-use CE-IVD test that improves the success rate of IVF-ET therapy
The success rate of IVF-ET therapy (20-25%) is still disappointing for couples and their caregivers. Evidence has accumulated showing that disturbances in the vaginal microbiota are an important and actionable biomarker for successful IVF-ET therapy. The VALBIOME project will develop and commercialise an easy-to-use CE-IVD certified test that enables physicians to assess and monitor the vaginal microbial status during IVF-ET therapy.
| Acronym | VALBIOME (Reference Number: 8884) |
| Duration | 01/09/2014 - 01/03/2017 |
| Project Topic | Biological Sciences / Technologies |
| Network | Eurostars 2 |
| Call | Eurostars Cut-Off 1 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 18096 | Microbiome | Coordinator | Netherlands |
| 18097 | ClinicaGeno | Partner | United Kingdom |
| 18098 | Universitäts Klinikum Bonn | Partner | Germany |
| 18099 | Qiagen | Partner | Germany |